The structure-based design of peptidomimetic inhibitors against SARS-CoV-2 3C like protease as Potent anti-viral drug candidate

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), as the pathogen of coronavirus disease 2019 (COVID-19), has infected millions of people and took hundreds of thousands of lives. Unfortunately, there is deficiency of effective medicines to prevent or treat COVID-19. 3C like protease (3CL...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hao, Pei, Rongjuan, Li, Xin, Deng, Weilong, Xing, Shuai, Zhang, Yanan, Zhang, Chen, He, Shuai, Sun, Hao, Xiao, Shuqi, Xiong, Jin, Zhang, Yecheng, Chen, Xinwen, Wang, Yaxin, Guo, Yu, Zhang, Bo, Shang, Luqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Masson SAS. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098890/
https://www.ncbi.nlm.nih.gov/pubmed/35635946
http://dx.doi.org/10.1016/j.ejmech.2022.114458

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098890/
https://www.ncbi.nlm.nih.gov/pubmed/35635946
http://dx.doi.org/10.1016/j.ejmech.2022.114458

Ejemplares similares